|
CA2277018C
(en)
*
|
1997-01-10 |
2006-10-03 |
Merck & Co., Inc. |
Use of angiotensin ii antagonists to treat symptomatic heart failure
|
|
US6201002B1
(en)
|
1997-01-10 |
2001-03-13 |
Merck & Co., Inc. |
Method for reducing mortality with an angiotensin II antagonist
|
|
US6306826B1
(en)
|
1997-06-04 |
2001-10-23 |
The Regents Of The University Of California |
Treatment of heart failure with growth hormone
|
|
HK1042252B
(en)
*
|
1999-03-05 |
2004-04-23 |
G.D. Searle Llc |
Combination therapy of angiotensin converting enzyme inhibitor and epoxy-steroidal aldosterone antagonist for treatment of cardiovascular disease
|
|
US6211217B1
(en)
|
1999-03-16 |
2001-04-03 |
Novartis Ag |
Method for reducing pericardial fibrosis and adhesion formation
|
|
US20030083342A1
(en)
*
|
2002-08-27 |
2003-05-01 |
Steele Ronald Edward |
Combination of organic compounds
|
|
JP2004501099A
(ja)
*
|
2000-05-11 |
2004-01-15 |
フアルマシア コーポレイション |
アルドステロン頂点位相時の放出のためのアルドステロンアンタゴニスト組成物
|
|
WO2001097805A2
(en)
*
|
2000-06-22 |
2001-12-27 |
Novartis Ag |
Solid valsartan pharmaceutical compositions
|
|
DE60127410T2
(de)
*
|
2000-07-27 |
2007-12-13 |
Pharmacia Corp. |
Kombinationstherapie mit epoxy-steroidalen aldosteronantagonisten und kalziumkanalblocker zur behandlung von kongestivem herzversagen
|
|
ES2269442T3
(es)
*
|
2000-07-27 |
2007-04-01 |
Pharmacia Corporation |
Terapia de combinacion de antagonista de aldosterona e inhibidor de ciclooxigenasa-2 para prevenir o tratar trastornos cardiovasculares relacionados con la inflamacion.
|
|
JP5082033B2
(ja)
|
2001-12-21 |
2012-11-28 |
エグゼリクシス パテント カンパニー エルエルシー |
Ｌｘｒのモジュレーター
|
|
US7482366B2
(en)
|
2001-12-21 |
2009-01-27 |
X-Ceptor Therapeutics, Inc. |
Modulators of LXR
|
|
AU2003233946A1
(en)
*
|
2002-03-15 |
2003-09-29 |
Novartis Ag |
4-(4-methylpiperazin-1-ylmethyl)-n-(4-methyl-3(4-pyridin-3-yl)pyrimidin-2-yl-amino)phenyl)-benzamide for treating ang ii-mediated diseases
|
|
GB0212412D0
(en)
*
|
2002-05-29 |
2002-07-10 |
Novartis Ag |
Combination of organic compounds
|
|
CL2004000545A1
(es)
*
|
2003-03-18 |
2005-01-28 |
Pharmacia Corp Sa Organizada B |
Uso de un antagonista de los receptores de aldosterona y un antagonista de receptores de endotelina para el tratamiento o profilaxis de una condicion patologica relacionada con hipertension, disfuncion renal, insulinopatia y enfermedades cardiovascul
|
|
US20050153885A1
(en)
*
|
2003-10-08 |
2005-07-14 |
Yun Anthony J. |
Treatment of conditions through modulation of the autonomic nervous system
|
|
US20070123498A1
(en)
*
|
2003-10-17 |
2007-05-31 |
Shetty Suraj S |
Combination of organic compounds
|
|
US8226977B2
(en)
|
2004-06-04 |
2012-07-24 |
Teva Pharmaceutical Industries Ltd. |
Pharmaceutical composition containing irbesartan
|
|
US8569277B2
(en)
|
2004-08-11 |
2013-10-29 |
Palo Alto Investors |
Methods of treating a subject for a condition
|
|
WO2006068760A2
(en)
|
2004-11-19 |
2006-06-29 |
The Regents Of The University Of California |
Anti-inflammatory pyrazolopyrimidines
|
|
CN101024643A
(zh)
*
|
2006-02-20 |
2007-08-29 |
上海艾力斯医药科技有限公司 |
咪唑－5－羧酸类衍生物、制备方法及其应用
|
|
US20080032960A1
(en)
|
2006-04-04 |
2008-02-07 |
Regents Of The University Of California |
PI3 kinase antagonists
|
|
US20110160232A1
(en)
|
2007-10-04 |
2011-06-30 |
Pingda Ren |
Certain chemical entities and therapeutic uses thereof
|
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
|
MX2010007418A
(es)
*
|
2008-01-04 |
2010-11-12 |
Intellikine Inc |
Ciertas entidades quimicas, composiciones y metodos.
|
|
US8993580B2
(en)
|
2008-03-14 |
2015-03-31 |
Intellikine Llc |
Benzothiazole kinase inhibitors and methods of use
|
|
US8637542B2
(en)
|
2008-03-14 |
2014-01-28 |
Intellikine, Inc. |
Kinase inhibitors and methods of use
|
|
JP5788316B2
(ja)
|
2008-07-08 |
2015-09-30 |
インテリカイン， エルエルシー |
キナーゼインヒビターおよび使用方法
|
|
US20110224223A1
(en)
|
2008-07-08 |
2011-09-15 |
The Regents Of The University Of California, A California Corporation |
MTOR Modulators and Uses Thereof
|
|
JP5731978B2
(ja)
|
2008-09-26 |
2015-06-10 |
インテリカイン， エルエルシー |
複素環キナーゼ阻害剤
|
|
US8697709B2
(en)
|
2008-10-16 |
2014-04-15 |
The Regents Of The University Of California |
Fused ring heteroaryl kinase inhibitors
|
|
US8476431B2
(en)
|
2008-11-03 |
2013-07-02 |
Itellikine LLC |
Benzoxazole kinase inhibitors and methods of use
|
|
TWI468410B
(zh)
|
2009-01-30 |
2015-01-11 |
Takeda Pharmaceutical |
稠環化合物及其用途
|
|
EP2427195B1
(en)
|
2009-05-07 |
2019-05-01 |
Intellikine, LLC |
Heterocyclic compounds and uses thereof
|
|
WO2011047384A2
(en)
|
2009-10-16 |
2011-04-21 |
The Regents Of The University Of California |
Methods of inhibiting ire1
|
|
WO2011146882A1
(en)
|
2010-05-21 |
2011-11-24 |
Intellikine, Inc. |
Chemical compounds, compositions and methods for kinase modulation
|
|
JP2013545749A
(ja)
|
2010-11-10 |
2013-12-26 |
インフィニティー ファーマシューティカルズ， インコーポレイテッド |
複素環化合物及びその使用
|
|
EP2663309B1
(en)
|
2011-01-10 |
2017-03-15 |
Infinity Pharmaceuticals, Inc. |
Processes for preparing isoquinolinones and solid forms of isoquinolinones
|
|
CN106619647A
(zh)
|
2011-02-23 |
2017-05-10 |
因特利凯有限责任公司 |
激酶抑制剂的组合及其用途
|
|
WO2013012918A1
(en)
|
2011-07-19 |
2013-01-24 |
Infinity Pharmaceuticals Inc. |
Heterocyclic compounds and uses thereof
|
|
EP2734520B1
(en)
|
2011-07-19 |
2016-09-14 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
CA2846431A1
(en)
|
2011-08-29 |
2013-03-07 |
Infinity Pharmaceuticals Inc. |
Heterocyclic compounds and uses thereof
|
|
WO2013077921A2
(en)
|
2011-09-02 |
2013-05-30 |
The Regents Of The University Of California |
Substituted pyrazolo[3,4-d]pyrimidines and uses thereof
|
|
US8809372B2
(en)
|
2011-09-30 |
2014-08-19 |
Asana Biosciences, Llc |
Pyridine derivatives
|
|
US9199975B2
(en)
|
2011-09-30 |
2015-12-01 |
Asana Biosciences, Llc |
Biaryl imidazole derivatives for regulating CYP17
|
|
US8940742B2
(en)
|
2012-04-10 |
2015-01-27 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
US8828998B2
(en)
|
2012-06-25 |
2014-09-09 |
Infinity Pharmaceuticals, Inc. |
Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
|
|
WO2014052669A1
(en)
|
2012-09-26 |
2014-04-03 |
The Regents Of The University Of California |
Modulation of ire1
|
|
MX375194B
(es)
|
2012-11-01 |
2025-03-06 |
Infinity Pharmaceuticals Inc |
Tratamiento de cánceres utilizando moduladores de las isoformas de pi3 cinasa.
|
|
US9481667B2
(en)
|
2013-03-15 |
2016-11-01 |
Infinity Pharmaceuticals, Inc. |
Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
|
|
SG10201902074UA
(en)
|
2013-10-04 |
2019-04-29 |
Infinity Pharmaceuticals Inc |
Heterocyclic compounds and uses thereof
|
|
WO2015051241A1
(en)
|
2013-10-04 |
2015-04-09 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
PT3119397T
(pt)
|
2014-03-19 |
2022-04-11 |
Infinity Pharmaceuticals Inc |
Compostos heterocíclicos para utilização no tratamento de distúrbios mediados por pi3k-gama
|
|
US20150320755A1
(en)
|
2014-04-16 |
2015-11-12 |
Infinity Pharmaceuticals, Inc. |
Combination therapies
|
|
WO2016054491A1
(en)
|
2014-10-03 |
2016-04-07 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
KR102787845B1
(ko)
|
2015-09-14 |
2025-03-31 |
트웰브 테라퓨틱스, 아이엔씨. |
이소퀴놀리논의 고체형, 그의 제조 방법, 이를 포함하는 조성물 및 이를 사용하는 방법
|
|
US10759806B2
(en)
|
2016-03-17 |
2020-09-01 |
Infinity Pharmaceuticals, Inc. |
Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K kinase inhibitors
|
|
US10919914B2
(en)
|
2016-06-08 |
2021-02-16 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
CN109640999A
(zh)
|
2016-06-24 |
2019-04-16 |
无限药品股份有限公司 |
组合疗法
|
|
KR102538999B1
(ko)
|
2016-06-29 |
2023-05-31 |
유니버시떼 드 몬트리얼 |
비아릴메틸 헤테로사이클
|
|
WO2018002673A1
(en)
|
2016-07-01 |
2018-01-04 |
N4 Pharma Uk Limited |
Novel formulations of angiotensin ii receptor antagonists
|
|
RS65963B1
(sr)
|
2018-10-29 |
2024-10-31 |
Myokardia Inc |
Tetrahidropiran (thp)-supstituisana biciklična jedinjenja pirimidindiona
|
|
AU2019387370A1
(en)
|
2018-11-30 |
2021-06-10 |
Nuvation Bio Inc. |
Pyrrole and pyrazole compounds and methods of use thereof
|
|
US12044455B2
(en)
|
2021-08-20 |
2024-07-23 |
Pioneer Family Brands, Inc. |
Ice shaver with thermally isolated shave deck
|
|
US11971205B2
(en)
|
2021-08-20 |
2024-04-30 |
Pioneer Family Brands, Inc. |
Ice shaver with splash guard
|
|
US11982483B2
(en)
|
2021-08-20 |
2024-05-14 |
Pioneer Family Brands, Inc. |
Ice shaver with multi-link control arm
|